|
Volumn 15 Suppl 3, Issue , 2010, Pages 30-32
|
Candidates for larynx preservation: the next step?
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
TAXOID;
HUMAN;
LARYNX;
LARYNX TUMOR;
MULTIMODALITY CANCER THERAPY;
PATIENT SELECTION;
REVIEW;
TIME;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
COMBINED MODALITY THERAPY;
FLUOROURACIL;
HUMANS;
LARYNGEAL NEOPLASMS;
LARYNX;
PATIENT SELECTION;
TAXOIDS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 79959543402
PISSN: None
EISSN: 1549490X
Source Type: Journal
DOI: 10.1634/theoncologist.2010-S3-30 Document Type: Review |
Times cited : (17)
|
References (0)
|